Literature DB >> 8185237

Inhibition of erythropoietin production by cytokines. Implications for the anemia involved in inflammatory states.

W E Jelkmann1, J Fandrey, S Frede, H Pagel.   

Abstract

In patients with the anemia of chronic diseases, the plasma level of EPO is often low in relation to the blood hemoglobin concentration. Because infectious and inflammatory processes cause activation of cytokine-producing macrophages and lymphocytes, we investigated whether isolated inflammatory cytokines influence the synthesis of EPO in vitro. IL-1 and TNF-alpha were shown to inhibit EPO mRNA levels and EPO formation in the human hepatoma cell cultures HepG2 and Hep3B, and to lower EPO formation in isolated perfused rat kidneys. IFN-alpha and IFN-beta also induced some inhibition of EPO production in HepG2 cultures. IL-3, TGF-beta 2, and IFN-gamma did not inhibit. IL-6 stimulated the production of EPO in Hep3B cells but was ineffective in HepG2 cells and lowered EPO production in isolated perfused rat kidneys. IL-1, TNF-alpha, and possibly other cytokines could contribute to defective EPO production in renal and nonrenal immune responses.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8185237

Source DB:  PubMed          Journal:  Ann N Y Acad Sci        ISSN: 0077-8923            Impact factor:   5.691


  15 in total

1.  Lupeol, a triterpenoid isolated from Calotropis gigantea latex ameliorates the primary and secondary complications of FCA induced adjuvant disease in experimental rats.

Authors:  Venkatesan Saratha; Sorimuthu Pillai Subramanian
Journal:  Inflammopharmacology       Date:  2011-10-16       Impact factor: 4.473

2.  Red Cell Distribution Width and Mortality in Hemodialysis Patients.

Authors:  Tania Vashistha; Elani Streja; Miklos Z Molnar; Connie M Rhee; Hamid Moradi; Melissa Soohoo; Csaba P Kovesdy; Kamyar Kalantar-Zadeh
Journal:  Am J Kidney Dis       Date:  2016-01-16       Impact factor: 8.860

3.  Interleukin 1 induces hypoxia-inducible factor 1 in human gingival and synovial fibroblasts.

Authors:  R D Thornton; P Lane; R C Borghaei; E A Pease; J Caro; E Mochan
Journal:  Biochem J       Date:  2000-08-15       Impact factor: 3.857

4.  Red blood cell distribution width at admission predicts outcome in critically ill patients with kidney failure: a retrospective cohort study based on the MIMIC-IV database.

Authors:  Rongqian Hua; Xuefang Liu; Enwu Yuan
Journal:  Ren Fail       Date:  2022-12       Impact factor: 3.222

5.  Medical decision support using machine learning for early detection of late-onset neonatal sepsis.

Authors:  Subramani Mani; Asli Ozdas; Constantin Aliferis; Huseyin Atakan Varol; Qingxia Chen; Randy Carnevale; Yukun Chen; Joann Romano-Keeler; Hui Nian; Jörn-Hendrik Weitkamp
Journal:  J Am Med Inform Assoc       Date:  2013-09-16       Impact factor: 4.497

6.  Plasma erythropoietin levels in anaemic and non-anaemic patients with chronic liver diseases.

Authors:  Cosimo Marcello Bruno; Sergio Neri; Claudio Sciacca; Gaetano Bertino; Pietro Di Prima; Danila Cilio; Rinaldo Pellicano; Luciano Caruso; Raffaello Cristaldi
Journal:  World J Gastroenterol       Date:  2004-05-01       Impact factor: 5.742

7.  Anemia in Crohn's disease. Importance of inadequate erythropoietin production and iron deficiency.

Authors:  C Gasché; W Reinisch; H Lochs; B Parsaei; S Bakos; J Wyatt; G F Fueger; A Gangl
Journal:  Dig Dis Sci       Date:  1994-09       Impact factor: 3.199

8.  Distinctive pharmacological differences between liver cancer cell lines HepG2 and Hep3B.

Authors:  Guo-Hua Qiu; Xiaojin Xie; Fang Xu; Xiaohao Shi; Yue Wang; Linhong Deng
Journal:  Cytotechnology       Date:  2014-07-08       Impact factor: 2.058

Review 9.  The role of iron repletion in adult iron deficiency anemia and other diseases.

Authors:  Benjamin Elstrott; Lubna Khan; Sven Olson; Vikram Raghunathan; Thomas DeLoughery; Joseph J Shatzel
Journal:  Eur J Haematol       Date:  2019-12-26       Impact factor: 2.997

10.  Phase 2, single-arm trial to evaluate the effectiveness of darbepoetin alfa for correcting anaemia in patients with myelodysplastic syndromes.

Authors:  Janice Gabrilove; Ronald Paquette; Roger M Lyons; Chaudhry Mushtaq; Mikkael A Sekeres; Dianne Tomita; Lyndah Dreiling
Journal:  Br J Haematol       Date:  2008-06-06       Impact factor: 6.998

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.